MIDATECH PHARMA PLC SPON ADS EACH REP 5 ORD BDRX 深 滬
交易中 12-19 10:11:30 美东时间
3.56
-0.590
-14.22%
華盛通- 最 高3.83
- 今 開3.71
- 成交量 16.68万股
- 最 低 3.5502
- 昨 收 4.15
- 總市值 220.54万
- 52周最高 92.00
- 市盈率 靜 --
- 換手率 26.93%
- 52周最低 3.5502
- 委 比 26.11%
- 總股本 61.95万
- 歷史最高 159417654.2112
- 量 比 0.65
- 振 幅 6.74%
- 歷史最低 3.5502
- 每 手 1
- 風險率 13.68%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Biodexa Pharmaceuticals Prices $10M Public Offering, Selling 157,000 ADS Units At $3.28 And 2.89M Pre-Funded Units
Biodexa Announces Pricing of $10 Million Public OfferingBiodexa Pharmaceuticals PLC, (NASDAQ:BDRX) ("Biodexa" or the "Company"), a clinical stage biopharmaceutical company developing a pipeline of innovative products for
12-18 21:40
Biodexa Prices $10M Public Offering
Biodexa Pharmaceuticals PLC, (NASDAQ:BDRX) ("Biodexa" or the "Company"), a clinical stage biopharmaceutical company developing a pipeline of innovative products for the treatment of diseases with unmet medical needs,
12-18 21:38
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Gainers Biodexa Pharmaceuticals (NASDAQ:BDRX) shares moved upwards by 38.7% to...
12-16 20:05
Why B. Riley Financial Shares Are Trading Higher By Around 25%; Here Are 20 Stocks Moving Premarket
Shares of B Riley Financial Inc (NASDAQ:RILY) rose sharply in pre-market tradin...
12-16 18:53
Why Mama's Creations Shares Are Trading Higher By Over 13%; Here Are 20 Stocks Moving Premarket
Shares of Mama’s Creations Inc (NASDAQ:MAMA) rose sharply in pre-market trading...
12-09 17:48
12 Health Care Stocks Moving In Tuesday's Intraday Session
Gainers Olema Pharmaceuticals (NASDAQ:OLMA) stock increased by 137.7% to $20.2...
11-19 01:06
Biodexa shares are trading higher after the company announced that the European Medicines Agency approved its clinical trial application for the Phase 3 Serenta trial.
Biodexa shares are trading higher after the company announced that the European...
11-03 21:38
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Gainers Bluejay Diagnostics (NASDAQ:BJDX) shares rose 113.4% to $3.99 during T...
10-09 20:07
Biodexa to Host Breakfast Symposium on FAP Mechanisms and Chemoprevention Trial Issues at CGA – IGC Conference on October 11, 2025
Biodexa Pharmaceuticals PLC will host a breakfast symposium on FAP mechanisms and chemoprevention trial issues at the CGA-IGC conference on October 11, 2025, in St. Louis, MO. Featuring guest speaker Dr. Patrick Lynch and a panel discussion with Drs. Sonia Kupfer and Paul Wise, the event aims to advance FAP treatment options and support Biodexa's Phase 3 Serenta trial for eRapa. Biodexa is focused on developing innovative therapies for unmet medi...
10-06 12:30
Biodexa Pharmaceuticals Files For Mixed Shelf Of Up To $100M
https://www.sec.gov/Archives/edgar/data/1643918/000121465925014255/b923250f3.htm
09-27 05:04
